An Experimental Study on Gene Therapy of Gastric Cancer by TK and Mil-2/Mgm-CSF Genes

顾琴龙,朱正纲,尹浩然,林言箴,郭善禹

DOI: https://doi.org/10.3760/j.issn:0254-1432.2001.03.003

2001-01-01

Abstract:Objective The TK (thymidine kinase) gene converts GCV to phosphorylated GCV, which inhibits the synthesis of cell DNA. Cytokines also play an important role in anti tumor immunity. IL 2 is a potent activator of T lymphacytes, natural killer cells, and lymphokine activated killer (LAK) cells; GM CSF can potentiate the release of granulocytes and macrophage cells, which transfer the anti tumor message to CD + 4 and CD + 8 T lymphocyte. We combined the TK and mIL 2/mGM CSF genes in order to produce more marked antitumor effect. Methods TK gene was constructed into the retroviral vector pLxSN, the mIL 2 and mGM CSF genes were inserted into the eukaryotic expressing vector pIRES. The gastric cancer cells were transfected by retroviral serum. The cytokine plasmids caped with liposome were injected into the tumor surrounding tissue. Results In vitro experiment, 20% of TK gene transduced cells could give rise to 70%～80% of total cells to death. In vivo results showed that no treatment effect was noted in control group. TK/GCV could inhibit the tumor growth. The strongest anti tumor effects were shown in TK+mIL 2+mGM CSF group. The pathologic examination showed necrosis in the treated groups.Conclusions TK/GCV can kill tumor cells and inhibit the tumor growth in vivo. IL 2 and GM CSF could significantly enhance the anti tumor effect. Through the retrovirus and liposome methods, the suicide gene and cytokine genes are all expressed in the tissues.